Arteriocyte Awarded $800,000 for Cellular Therapy

Arteriocyte will receive $800,000 for its Cellular Therapy for Battlefield Wounds project from the 2008 defense appropriations bill.

The therapy uses a patient’s stem cells to improve blood flow in damaged tissues and accelerate healing, Arteriocyte said.

Arteriocyte was launched four years ago based on technology developed at Case Western Reserve University and University Hospital’s Case Medical Center. The company develops non-embryonic stem cell-based therapies to treat ischemia.